Orange

Hospital visiting guidelines updated 20 July 2022: Hospital visitors must wear a surgical/medical paper mask. Fabric face coverings are no longer acceptable. See our COVID-19 pages for detailed information about hospital visiting guidelinesCOVID-19 tests and care in the community advice. See www.vaccinatecanterburywestcoast.nz for information about vaccinations.

We are at ORANGE according to the NZ COVID-19 Protection Framework

Last updated:
9th April 2022

  • For visitors to all facilities effective from Wednesday 20 July 2022With the recent resurgence in cases in Canterbury, largely due to the Omicron BA.5 subvariant we are seeing an increase in demand right across the health system. Presentations to our Christchurch ED and Ashburton’s AAU are higher than ever and admission rates are high, which means we have a shortage of resourced beds.Recently, we have seen too many unwell people coming to visit someone in hospital and too many that cannot or will not wear a medical mask. This increases the risk to vulnerable people in hospital. For these reasons we need to everything we can to minimise these risks.We have therefore tightened visitor restrictions for all Te Whatu Ora Waitaha Canterbury hospitals and health facilities.

    Kia whakahaumaru te whānau, me ngā iwi katoa – this is to keep everybody safe:

    • One visitor per patient in the hospital at any given time, except where stated otherwise in the ‘exceptions’ section below.
    • No visitors under 16 to any part of our facilities.
    • No visitors to COVID +ve patients other than in exceptional circumstances.
    • No eating or drinking at the bedside or anywhere other than cafes or areas designated for eating/drinking, as taking your mask off puts patients at risk.
    • Visitors or support people must not visit our facilities if they are unwell with cold or flu-like symptoms (even if they have tested negative) or have had a recent tummy bug.
    • Do not visit if you are COVID +ve or a household contact of someone who has tested positive
    • Surgical/medical masks must be worn at all times at all sites and will be provided if people don’t have them. Mask exemptions do not apply in our facilities – people who cannot tolerate a mask cannot visit at this time.
    • Hand sanitiser stations are visible and must be used.

    By sticking to the rules above, you help keep our patients, staff, other visitors and yourself safe. We thank you in advance for your patience and understanding as our staff work hard to protect and care for some of the most vulnerable in our community.

    Exceptions to the ‘one visitor’ policy

    • Exceptions can apply in some circumstances where trusted whānau members provide assistance, reassurance and other support for therapeutic care or on compassionate grounds – please talk to the ward’s Charge Nurse to discuss this before you come to hospital to visit. For whānau with an essential support role as a Partner in Care – again, please check with the ward’s Charge Nurse before you come to hospital to visit.
    • People attending Christchurch ED or Ashburton AAU can have one support person with them.
    • Women in labour and in the birthing suite can have two named support people + their community LMC/midwife if they have one – for the duration of the birth only. All other women on the Maternity Ward are allowed one support person for the duration of their stay in our facilities at Christchurch Women’s Hospital and other maternity units. Only one support person can be with each woman in the maternity ward, and one support person for maternity clinic appointments. No under 16s are allowed to visit or attend appointments.
    • Parents/caregivers can be with their baby in NICU.
    • Parents/caregivers are able to be with their child in hospital (Except Children’s Haematology and Oncology Day patients where only one parent or caregiver is permitted).
    • People requiring support when attending an appointment can have one support person. Please let the relevant service know if you need this so they are able to accommodate your request.

    Visiting patients with COVID-19

    • To avoid them becoming infected with COVID-19 and passing it one, visitors to COVID-19 positive patients will not be allowed except in extenuating circumstances – by prior agreement with the Charge Nurse Manager only, and wearing an N95 mask.
    • Other methods of communication will be facilitated e.g. phone, facetime, zoom etc.

    You must NOT visit the hospital if you

    • are a household contact of a COVID-19 positive case
    • are COVID-19 positive
    • Have a cold or flu/COVID-19-like symptoms (even if you are testing negative for COVID-19)

    Exceptions for people with disabilities

    An exception will be made for people with disabilities who are in hospital or have to attend an outpatient appointment – where they need a support person to access health services. For example, a sign language interpreter, support person for someone with a learning disability, or someone to assist with mobility. The support person is in addition to the one permitted visitor.

    Everyone visiting our facilities must wear a mask, no exceptions

    While we appreciate that some people have legitimate reasons for being exempt from wearing a mask and may even have an official card to confirm this, people who cannot or will not wear a mask cannot visit someone in hospital or attend hospital, other than to access healthcare. This is another measure to minimise the risk to vulnerable patients.

    Patients and visitors should also read the additional more detailed visiting guidelines for each specific hospital.

    More COVID-19 information

Manganese, Blood

Diagnostic Use

Manganese is an essential micronutrient found throughout the body, with the highest levels found in the liver. It accumulates in tissues high in mitochondria and is a cofactor in enzymes such as hexokinase, superoxide dismutase and xanthine oxidase. Manganese is associated with bone and tissue formation, carbohydrate metabolism, reproductive processes and lipid metabolism. Manganese is absorbed through the gastrointestinal tract with absorption being similar to iron absorption. Manganese is mainly excreted in bile with only a small amount excreted in urine. The human requirement for manganese is very low and even during prolonged TPN no clear evidence of deficiency has been documented. However because of the potential importance of manganese, additives containing it have been included in TPN regimens.
The concentration of whole blood manganese is about 10 times higher than in serum therefore the manganese from contamination is proportionately less significant, eliminating some sampling precautions. Whole blood manganese may better reflect manganese stores in tissue therefore it is recommended to use whole blood samples for assessment of manganese status and long term occupational exposure. Manganese is used in iron, steel and battery production industries. Occupational exposure to manganese is through the lungs via inhalation during mining of manganese ores and welding of mild steel (used as a toughening agent). Permanganate compounds are used in glass and ceramics industries and are also used as powerful oxidising agents.

Toxic effects
Exposure to high levels of manganese can cause non-specific symptoms and signs of neurological deterioration including irritability, apathy asthenia, headaches, lethargy and weakness in the extremities and in a few cases can lead to Parkinson's disease. These symptoms are believed to arise due to excess manganese deposition in the basal ganglia which can be seen as hyper-intense areas on MRI of the brain.
Manganese toxicity has also been documented in patients on long term TPN who are particularly at risk if there is liver dysfunction. Increased whole blood manganese has also been reported in liver disease, rheumatoid arthritis and iron deficiency anaemia. Neurological effects exhibit Parkinson like symptoms, including behavioral and emotional disturbances, if diagnosed in the early stages these effects can be reversed. Some haematological changes may also be observed, such as greatly reduced white cell count (leucopoenia) and lymphocytosis, or an increase in haemoglobin count. However in some cases there may be no changes at all.

Department

Lipids/Trace Metals

Delphic Registration Code

BMN

Turnaround Time

7 days

Test Code

6400